Affiliation: University of Maryland
- Blockade of the renin-angiotensin system in African Americans with hypertension and cardiovascular diseaseElijah Saunders
Division of Cardiology, Section of Hypertension, University of Maryland School of Medicine, Baltimore, MD
J Clin Hypertens (Greenwich) 5:12-7. 2003..Although further confirmation in additional clinical trials is required, increased use of these agents in African Americans will likely result in a reduction in target organ damage...
- Epidemiology of atherothrombotic disease and the effectiveness and risks of antiplatelet therapy: race and ethnicity considerationsElijah Saunders
Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
Cardiol Rev 16:82-8. 2008..Thus, understanding and overcoming race and ethnicity-related treatment disparities should lead to significant clinical improvements in these under-served populations...
- The efficacy and tolerability of nebivolol in hypertensive African American patientsElijah Saunders
Section of Hypertension, University of Maryland School of Medicine, Baltimore, MD 21201, USA
J Clin Hypertens (Greenwich) 9:866-75. 2007..Nebivolol monotherapy provides antihypertensive efficacy, with few significant adverse effects, in hypertensive African Americans...
- Managing hypertension in African-American patientsElijah Saunders
Division of Cardiology, University of Maryland School of Medicine, 419 West Redwood Street, Baltimore, MD 21201 1734, USA
J Clin Hypertens (Greenwich) 6:19-25. 2004..Based on these findings, recommendations are made for the optimal clinical management of hypertension in African-American patients...
- Building on the specialist's antihypertensive treatment recommendation: it's just the beginningElijah Saunders
University of Maryland School of Medicine, Baltimore, MD 21201, USA
J Clin Hypertens (Greenwich) 8:31-9. 2006..With the availability of effective and safe antihypertensive drug therapies, including fixed-dose combinations, a BP goal of <140/90 mm Hg should be achievable in most patients...
- Readmissions after unauthorized discharges in the cardiovascular settingEberechukwu Onukwugha
Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
Med Care 49:215-24. 2011....
- The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American populationWallace Johnson
School of Medicine, University of Maryland, Baltimore, MD, USA
J Clin Hypertens (Greenwich) 13:563-70. 2011..Additional research should be conducted to evaluate whether the use of certified hypertension educators in collaboration with physicians will result in a similar blood pressure reduction...
- Social networks help control hypertensionFadia T Shaya
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
J Clin Hypertens (Greenwich) 15:34-40. 2013..The clustering of patients in social networks around hypertension education has a positive impact on the management of hypertension in minority populations and may help address cardiovascular health disparities...
- Diabetes knowledge in a high risk urban populationFadia T Shaya
Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, 2nd Floor, Baltimore, MD 21201, USA
Ethn Dis 21:485-9. 2011..0104). The study indicated that patients who are exposed to the educational program end up with better knowledge on all counts, than patients who just go through the health care system in the course of usual care for diabetes...
- Barriers to self-management of diabetes: a qualitative study among low-income minority diabeticsNneka C Onwudiwe
University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Baltimore, Maryland 21201, USA
Ethn Dis 21:27-32. 2011..Our goal was to explore patients' perceptions about barriers to self-management of diabetes that could possibly help explain poor health outcomes among minority patients...
- Medicaid managed care: disparities in the use of thiazolidinediones compared with metforminFadia T Shaya
Outcomes Research Epidemiology Center on Drugs and Public Policy University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
J Natl Med Assoc 97:493-7. 2005..To identify patient characteristics that are associated with the incidence of thiadolidinediones (TZDs) or metformin prescnbing in Medicaid managed care plans...
- A qualitative evaluation of a citywide Community Health Partnership programC Daniel Mullins
University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Saratoga Building, 12th Floor, 220 Arch St, Baltimore, MD 21201, USA
J Natl Med Assoc 104:53-60. 2012..Through stakeholder engagement, many more communities beyond Baltimore can become better networked to help patients navigate the health care system and improve their health...
- Predictors of blood pressure response to angiotensin receptor blocker/diuretic combination therapy: a secondary analysis of the irbesartan/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) studyElijah Saunders
Division of Cardiology, Section of Hypertension, University of Maryland School of Medicine Baltimore, MD, USA
J Clin Hypertens (Greenwich) 10:27-33. 2008..In conclusion, a significant correlation may exist between certain clinical/demographic characteristics and the extent of the therapeutic response with irbesartan/hydrochlorothiazide treatment...
- Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular diseaseEbere Chukwu Onukwugha
Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
Ethn Dis 19:172-8. 2009..Disparities in discharges AMA have not been examined among patients with cardiovascular disease, nor has the moderating role of hospital quality been studied...
- Reasons for discharges against medical advice: a qualitative studyEberechukwu Onukwugha
Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
Qual Saf Health Care 19:420-4. 2010..The objective of this study is to identify the reasons for DAMA based on patient and multicategory provider focus-group interviews (FGIs)...
- A perspective on African American participation in clinical trialsFadia T Shaya
Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Pharmaceutical Health Services Research, 220 Arch Street, Baltimore, MD 21201, USA
Contemp Clin Trials 28:213-7. 2007....
- Hypertension in black Americans as a special population: why so special?David Stewart
Section of Hypertension, Division of Cardiology, University of Maryland School of Medicine, 419 West Redwood Street, Baltimore, MD 21201, USA
Curr Cardiol Rep 8:405-10. 2006..This article reviews the varied aspects of hypertension detection, treatment, and control as they relate to the special population of black Americans...
- Addressing cardiovascular disparities through community interventionsFadia T Shaya
Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
Ethn Dis 16:138-44. 2006..To identify the components and impact of intervention programs aimed at reducing cardiovascular disparities...
- Health care cost of analgesic use in hypertensive patientsC Daniel Mullins
Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
Clin Ther 26:285-93. 2004..Hypertension is one of the most frequently diagnosed chronic medical conditions in the United States and imposes a substantial financial and social burden on Americans...
- Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scoresFadia T Shaya
Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, 2nd Floor, Baltimore, MD 21201, USA
Expert Rev Pharmacoecon Outcomes Res 5:625-32. 2005..Misclassification bias was accounted for by adjusting for length of drug exposure...
- Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patientsJohn M Flack
Department of Internal Medicine, Wayne State University, Detroit, Michigan 48201, USA
J Am Coll Cardiol 41:1148-55. 2003..The purpose of this study was to evaluate the efficacy and tolerability of monotherapy with the selective aldosterone blocker eplerenone in both black and white patients with hypertension...
- Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in BlacksJanice G Douglas
Case Western Reserve University, Department of Medicine, Room W 165, 10900 Euclid Ave, Cleveland, Ohio 44106, USA
Arch Intern Med 163:525-41. 2003
- Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trialElizabeth O Ofili
Morehouse School of Medicine, Atlanta, Georgia 30310, USA
J Womens Health (Larchmt) 17:931-8. 2008....
- Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertensionWilliam B White
Section of Hypertension and Clinical Pharmacology, Department of Medicine, University of Connecticut School of Medicine, 263 Farmngton Avenue, Farmington, CT 06032, USA
Am J Hypertens 16:739-45. 2003....
- Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing GroupSidney C Smith
Circulation 111:e134-9. 2005
- Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetesJames R Sowers
University of Missouri Columbia and Harry S Truman VA Medical Center, 65212, USA
J Clin Hypertens (Greenwich) 8:470-80. 2006..Irbesartan/HCTZ fixed combinations achieved SBP goals in over half of the T2DM patients and nearly three quarters of patients with the metabolic syndrome, with SBP uncontrolled on antihypertensive monotherapy...
- Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trialJohn M Flack
Department of Medicine, Wayne State University, Detroit, MI 48201, USA
Mayo Clin Proc 83:35-45. 2008..To investigate the efficacy and safety of single-pill amlodipine/atorvastatin therapy for the simultaneous treatment of hypertension (HTN) and dyslipidemia in African Americans...
- Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapyElizabeth O Ofili
Clinical Research Center, Morehouse School of Medicine, Atlanta, GA 30310, USA
J Natl Med Assoc 98:618-26. 2006..In conclusion, irbesartan/HCTZ treatment provided SBP/DBP goal attainment in approximately two-thirds of Caucasian, African-American and Hispanic/Latino patients with SBP uncontrolled on antihypertensive monotherapy...
- The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trialJoel M Neutel
Orange County Research Center, Tustin, CA 92780, USA
J Clin Hypertens (Greenwich) 7:578-86. 2005..Treatments were well tolerated. This irbesartan/HCTZ treatment regimen achieved SBP goals in more than 75% of patients uncontrolled on monotherapy...
- Hypertension-related morbidity and mortality in African Americans--why we need to do betterKeith C Ferdinand
Heartbeats Life Center, Xavier University College of Pharmacy, New Orleans, LA, USA
J Clin Hypertens (Greenwich) 8:21-30. 2006..These comorbidities are more common in African Americans and indicate the potential need for initial therapy with more than one agent or a combination of agents in one pill...
- Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trialEvan Mokwe
Department of Internal Medicine, Wayne State University, Detroit, Mich 48201, USA
Hypertension 43:1202-7. 2004....
- Racial disparities in hypertension prevalence, awareness, and managementRobin P Hertz
US Outcomes Research Population Studies, Pfizer Global Pharmaceuticals, New York, NY 10017, USA
Arch Intern Med 165:2098-104. 2005..Effectively reducing cardiovascular disease disparities requires identifying and reducing disparities in risk factors. Improved understanding of hypertension disparities is critical...
- The metabolic syndrome: recognition and managementW Dallas Hall
Emory University School of Medicine, Atlanta, GA, USA
Dis Manag 9:16-33. 2006..Pharmacotherapy is typically needed for control of high blood pressure, hypercoagulability, and increased levels of blood glucose and triglycerides...
- Cardioprotective strategies to improve long-term outcomes following coronary artery bypass surgeryRohit Arora
Department of Medicine, Robert Wood Johnson University Hospital, New Brunswick, New Jersey
J Card Surg 21:198-204. 2006....
- The Metabolic Syndrome in African Americans: a reviewW Dallas Hall
African American Lipid and Cardiovascular Council, USA
Ethn Dis 13:414-28. 2003..This comprehensive review is provided as part of the educational activities of the African-American Lipid and Cardiovascular Council (AALCC)...
- Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapyWilliam C Cushman
University of Tennessee College of Medicine and Veterans Affairs Medical Center, Memphis, TN, USA
Am J Geriatr Cardiol 17:27-36. 2008..Irbesartan/HCTZ combination therapy allowed SBP goal attainment in 73% of patients aged 65 years or older whose hypertension was previously uncontrolled with antihypertensive monotherapy...
- Partnership Program to Reduce Cardiovascular DisparitiesElijah Saunders; Fiscal Year: 2008..We strongly expect improved outcomes/awareness of cardiovascular health among minority patients serviced by both BSBHS and UMB. ..